Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Seeger

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studiesD O Stram, K K Matthay, M O'Leary, et al.
Journal of the National Cancer Institute|May 18, 1994
Hsp27 expression in neuroblastoma: correlation with disease stageD R Ungar, N Hailat, J R Strahler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Parental smoking and alcohol consumption and risk of neuroblastomaQ Yang, A F Olshan, M L Bondy, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer GroupR Cooper, Y Khakoo, K K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumorsM F Ozkaynak, K Matthay, M Cairo, et al.
Cancer Research|February 17, 2000
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramideA Erdreich-Epstein, H Shimada, S Groshen, et al.
Cancer|December 18, 2001
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer GroupS Goto, S Umehara, R B Gerbing, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group StudyE Rudnick, Y Khakoo, N L Antunes, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitroJ A Hank, J Surfus, J Gan, et al.
Medical and Pediatric Oncology|May 20, 1998
Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastomaS S Goldberg, K DeSantes, J P Huberty, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studiesD O Stram, K K Matthay, M O'Leary, et al.
Journal of the National Cancer Institute|May 18, 1994
Hsp27 expression in neuroblastoma: correlation with disease stageD R Ungar, N Hailat, J R Strahler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Parental smoking and alcohol consumption and risk of neuroblastomaQ Yang, A F Olshan, M L Bondy, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer GroupR Cooper, Y Khakoo, K K Matthay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumorsM F Ozkaynak, K Matthay, M Cairo, et al.
Cancer Research|February 17, 2000
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramideA Erdreich-Epstein, H Shimada, S Groshen, et al.
Cancer|December 18, 2001
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer GroupS Goto, S Umehara, R B Gerbing, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group StudyE Rudnick, Y Khakoo, N L Antunes, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitroJ A Hank, J Surfus, J Gan, et al.
Medical and Pediatric Oncology|May 20, 1998
Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastomaS S Goldberg, K DeSantes, J P Huberty, et al.
Pageof 16